Sched.com Conference Mobile Apps
bwge2017
has ended
Create Your Own Event
bwge2017
Schedule
Simple
Expanded
Grid
By Venue
Speakers
Search
or browse by date + venue
Basic short talks oral poster session
BASL Meeting
All
SESSION 1
SESSION 2
SESSION 3
SESSION 4
BeSPGHAN
All
Pharmacology in children - Session 1
Pharmacology in children - Session 2
BGDO
All
Highlights of the year
SESSION 1
Sesssion 2
BINA Nurses
All
SESSION 1
SESSION 2
BSGIE Symposium
All
SESSION 1
SESSION 2
Clinical short talks oral poster session
IBD/BIRD Session
All
SESSION 1
SESSION 2
SESSION 3
SESSION 4
Interactive Case Report Session
All
SESSION 1
SESSION 2
Plenary Session
All
SESSION 1
SESSION 2
Research Group: Belgian Pancreatic Club (BPC)
All
SESSION 1
SESSION 2
Research Group : GIREM 'Gastrointestinal regulatory mechanisms'
All
SESSION 1
SESSION 2
SESSION 3
SESSION 4
Satellite Symposia
Ultrasound Course
Working Group of Digestive Pathology
All
SESSION 1
SESSION 2
SESSION 3
SESSION 4
SESSION 5
Young BASL
Sign up
or
log in
to bookmark your favorites and sync them to your phone or calendar.
menu
Menu
Schedule
Speakers
Search
tune
Filter sessions
Simple
Expanded
Grid
By Venue
Thursday
, February 9
Belle Epoque 3rd floor
12:00 •
Increased non-shivering thermogenesis had preventive but no therapeutic effects on non-alcoholic steatohepatitis
12:00 •
Hair ethyl glucuronide is a highly accurate and objective biomarker of continued alcohol use in patients with alcoholic cirrhosis
12:00 •
MET deletion in MRP8+ neutrophils is protective during DDS-induced colitis via Th17 pathway
12:00 •
Non-sense mediated RNA decay regulates the unfolded protein response during hepatic stellate cell activation
12:00 •
Ursodeoxycholic acid and its taurine/glycine conjugated species reduce colitogenic dysbiosis and equally suppress experimental colitis in mice
12:00 •
Identification of proteins discriminating inflammation induced dysplasia from simple inflammation in ulcerative colitis by laser capture microdissection and label free proteomics – a pilot study
12:00 •
Intestinal organoids derived from inflamed tissues reach transcription levels comparable to non-inflamed tissues and healthy controls
12:00 •
Isolation and characterisation of hepatic progenitor cells from human alcoholic livers identify a new player: IL-17A
Exhibition Area Room Belle
10:00 •
Coffee break
10:15 •
Coffee Break
10:30 •
Coffee Break
12:00 •
Lunch
12:30 •
Lunch
15:30 •
Coffee break
15:30 •
Coffee break
15:30 •
Coffee break
15:45 •
Coffee Break
Room FLORENTINE 2nd floor
17:00 •
Ultrasound Course
Room LIJN 3rd floor
08:30 •
HMGB1-driven Feedforward Hepatocyte Necroptosis Circuit in Lethal Acetaminophen-induced liver injury.
08:40 •
Characterization of a tertiary center PBC cohort and validation of prognostic risk scores
08:50 •
Lipid, fetuin-A and macrophage zonation in high fat diet foz-foz mice with non-alcoholic steatohepatitis
09:00 •
Serum vascular cell adhesion molecule-1 predicts significant liver fibrosis in obese patients with non-alcoholic fatty liver disease
09:10 •
Ubiquitin Carboxy-terminal Hydrolase L1 expression is increased in hepatocellular carcinoma cells and renders those cells more sensitive to ER stress-induced cell death following inhibition.
09:20 •
Do or don’t: HCV screening in the Belgian Baby Boom Cohort.
09:30 •
ECV-associated miRNA levels as non-invasive biomarkers for early-stage HBV/HCV-induced liver fibrosis
09:40 •
Pretransplant glycomic analysis of perfusate is predictive of primary non function after liver transplantation
09:50 •
A glycomic serum marker analysed at one week after liver transplantation is an independent predictor of graft loss during the first year after liver transplantation
10:30 •
Relapse rates and clinical outcomes after Nucleos(t)ide Analogue therapy stop in a Belgian, predominantly Caucasian cohort of Chronic Hepatitis B patients
10:42 •
LIVER FIBROSIS PROMOTES HEPATOCARCINOMA GROWTH THROUGH INFILTRATION BY TUMOR-ASSOCIATED INFLAMMATORY CELLS
10:54 •
Paired biopsy analysis of human liver transcriptome before and 1 year after bariatric surgery identifies a restricted set of inflammation- and extracellular matrix-related genes as pivotal in NASH and fibrosis pathogenesis
11:06 •
Liver progenitor cells significantly contribute to hepatocyte pool in chronic liver injury and cirrhosis: a kinetic study in mice.
11:18 •
Early TIPS placement as a feasible and safe strategy for variceal bleeding in high risk liver patients: a 5-year monocentre experience.
11:30 •
BLIC Lecture: Liver Transplantation in acute on chronic liver failure
12:00 •
MSD Satellite symposium
12:00 •
Satellite Symposium MSD
13:15 •
BMS Satellite Symposium
13:15 •
Satellite Symposium BMS
14:00 •
Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): establishment of a unique, innovating animal model with insufficient liver remnant.
14:12 •
The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C infected patients treated with direct acting antivirals with and without Pegylated Interferon: A Belgian experience.
14:24 •
Pegylated interferon alpha treatment rapidly clears Hepatitis E Virus infections in humanized mice.
14:36 •
Personalized subcutaneous administration of hepatitis B surface antibodies without nucleos(t)ide analogues is highly effective and reduces cost for hepatitis B prophylaxis after liver transplantation
14:48 •
PPARα-regulated dermatopontin is an important contributor to the liver fibrotic response in mouse models and has relevance to fibrosis progression in NAFLD patients.
15:00 •
MARC HAUTEKEETE LECTURE : Do direct antiviral agents for HCV increase risk of hepatocellular carcinoma : fact, fiction or undecided?
16:00 •
Kupffer cell pool is maintained by local proliferation and the differentiation of bone marrow monocytes into short-lived monocyte-derived Kupffer cells during non-alcoholic steatohepatitis and recovery
16:10 •
Cessation of Nucleos(t)ide Analogue therapy after HBeAg seroconversion is associated with a decreased chance of HBsAg loss in a Belgian, predominantly Caucasian cohort of chronic hepatitis B patients
16:20 •
A new classification of chronic portal vein occlusion for assessing the feasibility of recanalization in non-cirrhotic patients
16:30 •
The prevalence of cardiac induced liver disease in patients with a chronic right heart disorder.
16:40 •
Invited Lecture : introducing the mandatory registration of follow-up data for patients treated with antiviral hepatitis C medication
17:00 •
BASL Awards for best Basic and Clinical work presented and Update on e-health requirement and BASL General Assembly
Room Sancy 2nd floor
09:00 •
An important role for serine proteases such as tryptase in a post-inflammatory rat model for visceral hypersensitivity.
09:15 •
Evidence for TRP channel sensitization in IBS with histamine 1 receptor antagonism as effective treatment.
09:30 •
Food antigen-specific antibodies and mast cell activation in post-infectious visceral hypersensitivity
09:45 •
Mast cells mediate Staphylococcal enterotoxin B-triggered visceral hypersensitivity: potential link between superantigens and Irritable Bowel Syndrome (IBS)
10:00 •
Expression of a novel family of pain-related G protein-coupled receptors in the human intestine: a comparison between healthy and irritable bowel syndrome-affected ileum.
10:45 •
INVITED LECTURE: THE ROLE OF THE AUTONOMIC NERVOUS SYSTEM IN MODULATING PAIN AND INFLAMMATION
11:30 •
Phosphodiesterase 3A is more than an ICC marker
11:45 •
Influence of phosphodiesterases on basal and 5-HT4 receptor-facilitated cholinergic contractility in the murine gastrointestinal tract
12:00 •
Vagus nerve stimulation and prucalopride have anti-inflammatory properties and improve postoperative ileus in human
12:15 •
Dimethyl fumarate improves murine postoperative ileus independently of heme oxygenase-1
14:00 •
INVITED LECTURE: NOVEL THERAPEUTICS FOR DIABESITY, FROM ULTIAGONISTS TO PRECISION MEDICINE.
14:45 •
Effect of obesity on the bitter and sweet chemosensory signalling pathways that regulate ghrelin release in the human gut
15:00 •
Effect of diet-induced obesity on serotonergic enteric neurons and intestinal transit in the zebrafish
15:15 •
Live calcium and mitochondrial imaging in the enteric nervous system of Parkinson patients and controls
15:30 •
Foetal intraperitoneal AAV8 injections results in the specific targeting of myenteric neurons in the mouse gastrointestinal tract.
16:15 •
Influence of acute tryptophan depletion on oesophageal sensitivity and visceral pain perception in health
16:30 •
A double-blind, placebo-controlled trial with baclofen for the treatment of refractory gastro-esophageal reflux disease
16:45 •
The Waiting Room Questionnaire: validation of a novel patient reported outcome questionnaire for the diagnosis of functional gastrointestinal disorders
17:00 •
Concluding Remarks
Room TEUN 3rd floor
09:00 •
Transmission of live endoscopy
09:30 •
Invited lecture: Development of performance measures for endoscopy.
09:30 •
Invited Lecture: Performance measures in upper GI Endoscopy.
14:00 •
Endoscopic Submucosal Dissection for early esophageal neoplasia. A single operator study.
14:15 •
Diagnostic Yield of Capsule Enteroscopy in Patients with Iron Deficiency Anemia: Results of a Single Centre Retrospective Study
14:30 •
Efficacy, safety and learning curve of Endoscopic Submucosal Dissection in a consecutive case series by a single operator in the West.
14:45 •
Endoscopic submucosal dissection for duodenal lesions: adverse events and follow up
15:00 •
Invited Lecture : Management of DALM: detection and endoscopic management
16:00 •
Colonoscopy quality: implementation of colonoscopy quality monitoring in a Belgian university hospital.
16:12 •
Electromagnetic-guided placement of a nasojejunal tube in patients receiving fecal microbiota transplantation
16:24 •
Cold snare polypectomy for advanced, flat sessile lesions
16:36 •
Current Utilization and Diagnostic Yield of Random Colonic Biopsies in Evaluation of Chronic Diarrhea
16:50 •
Invited Lecture: The good and bad news in digestive endoscopy coding and fees
Room TIFFANY/SHAH 2nd floor
14:00 •
INVITED LECTURE: Mechanisms of fibrosis in the GI tract and potential targets for therapeutic intervention.
14:30 •
Metagenomics and metabolomics of patients with inflammatory bowel disease and their unaffected relatives
14:40 •
Defects in ER stress and autophagy genes translate into increased functional ER stress levels in patients with inflammatory bowel disease
14:50 •
Increased baseline TNF-driven pathways observed in patients with Crohn’s disease not responding to infliximab
15:00 •
INVITED LECTURE: Small animal imaging: Applications in IBD preclinical research
16:00 •
Molecular profiling of early Crohn’s disease reveals a prominent role for WNT5A
16:10 •
Nafamostat mesilate, a serine protease inhibitor, ameliorates chronic colitis via suppression of T-bet.
16:20 •
Mucosal recolonization after ileocecal resection differs in Crohn’s disease patients developing postoperative recurrence
16:30 •
INVITED LECTURE: The gut-brain axis: implications for IBD?
TIFFANY/SHAH 2nd floor
09:00 •
ESGE Guidelines on Endoscopic Pancreatic Necrosectomy
09:30 •
Single versus multiple pancreatic stents in chronic pancreatitis: a retrospective clinical study
09:45 •
MULTIDISCIPLINARY APPROACH DURING LONG-TERM FOLLOW-UP IS ESSENTIAL AFTER SURGERY FOR CHRONIC PANCREATITIS TO ACHIEVE BEST PATIENT OUTCOME
10:00 •
Pancreatic exocrine insufficiency after pancreaticoduodenectomy is more prevalent with pancreaticogastrostomy than with pancreaticojejunostomy. A retrospective multicentre observational cohort study.
10:15 •
AUTOIMMUNE PANCREATITIS IN CHILDREN: WORKING GUIDELINES FOR DIAGNOSIS AND MANAGEMENT
11:00 •
Suppurative cholangitis in chronic pancreatitis: report of a rare stone related complication.
11:12 •
How to place a self expandable metal stent (SEMS) into the afferent limb after a Roux-en-Y Whipple resection using the single-balloon enteroscope ?
11:24 •
Multivisceral transplantation for portomesenteric thrombosis and unresectable neuroendocrine tumor
11:36 •
Splenic neuroendocrine tumor metastasis or simple splenic cyst?
11:48 •
Atypical tumor in the pancreatic head?
17:00 •
MUNDIPHARMA Sattelite Symposium
Friday
, February 10
Belle Epoque 3rd floor
12:00 •
Serum marker panel for early detection of endoscopic healing with infliximab in patients with ulcerative colitis
12:00 •
The influence of Direct Acting Antivirals on extrahepatic manifestations of the hepatitis C Virus.
12:00 •
Esophagitis dissecans superficialis: A case series of 7 patients of a misdiagnosed entity
12:00 •
PROFILE study: prospective evaluation of step up therapy in patients with early UC in Belgium
12:00 •
Antibiotics induce remission in pediatric PSC-AIH overlap syndrome allowing corticosteroid-free therapy
Exhibition Area Room Belle
09:50 •
Coffee break
10:05 •
Coffee break
10:15 •
Coffee break
11:45 •
Lunch
15:20 •
Coffee break
15:30 •
Coffee break
15:30 •
Coffee break
Room FLORENTINE 2nd floor
14:00 •
Ultrasound Course
Room LIJN 3rd floor
07:45 •
ALLERGAN Satellite Symposium
08:30 •
INVITED LECTURE: Management of fibrostenosing Crohn’s disease.
09:00 •
Perioperative use of vedolizumab is not associated with short-term postoperative infectious complications in patients with ulcerative colitis undergoing (procto)colectomy with ileal pouch-anal anastomosis
09:10 •
Adalimumab dose escalation and de-escalation in UC: incidence and predictors of success: a real life Belgian cohort study.
09:20 •
Correlation of durability of response, serum trough concentrations and outcome parameters: long-term follow-up of the Trough Concentration Adapted Infliximab Treatment (TAXIT) trial.
09:30 •
Recent Anti-TNF Exposure Predicts Lower Vedolizumab Trough Concentrations in Patients with Crohn Disease
09:40 •
Natural history of dysplasia and colorectal cancer in inflammatory bowel disease in Belgium tertiary care centers
10:20 •
INVITED LECTURE : Evolving therapeutic algorithms in UC.
10:50 •
Anti-Infliximab Antibody Concentrations Guide Therapeutic Decision-Making in Patients with Crohn’s Disease Losing Clinical Response
11:00 •
Filgotinib, a selective JAK1 inhibitor, induces clinical remission in patients with moderate-to-severe Crohn’s disease: results from the Phase 2 FITZROY study
11:10 •
IBD nurses as integral part of a multidisciplinary IBD team: prospective study on view on patient outcomes
11:20 •
INVITED LECTURE: Evolving therapeutic algorithms in CD.
12:00 •
TAKEDA Satellite Symposium
13:15 •
SANOFI Satellite Symposium
14:00 •
Primary tumor sidedness has an impact on prognosis and treatment outcome: results from three randomized studies of panitumumab plus chemotherapy versus chemotherapy (plus bevacizumab) in 1st and 2nd line RAS/BRAF WT mCRC
14:13 •
Interleukin 15-stimulated natural killer cells can kill both pancreatic cancer and stellate cells
14:26 •
Characterization of the immune microenvironment and relation to preoperative treatment of synchronous resection of primary tumor and liver colorectal cancer metastases.
14:39 •
Prognostic relevance of pancreatic neuroendocrine tumors grading on EUS-FNA
14:52 •
Retrospective study on the incidence of chemotherapy side effects and evaluation of the Hurria score and G8 CGA as predictive tools for toxicity in older patients with gastrointestinal cancer.
15:05 •
Pressurized intraperitoneal aerosol chemotherapy (PIPAC), a new surgical technique for the treatment of unresectable peritoneal carcinomatosis
15:45 •
State-of-the-art lecture: Treatment of borderline resectable pancreatic Cancer: what is the optimal induction treatment?
16:15 •
Upper GI cancers
16:40 •
Hepato-Bilio-Pancreatic cancers
17:05 •
Colo-Rectal cancers
17:30 •
CELGENE Satellite Symposium
Room Sancy 2nd floor
09:00 •
A rare complication of totally extraperitoneal hernia repair detected by colonoscopy
09:15 •
Post-liver transplantation follow-up over 17 years for mild Zellweger spectrum disorder and additional cases
09:30 •
Endoscopic gastrojejunostomy using the HotAxios lumen apposing metal stent to treat malignant gastric outlet syndrome.
09:45 •
Esophageal intramural pseudodiverticulosis complicated by a pneumomediastinum.
10:00 •
Meckel’s enterolith: a rare cause of small bowel obstruction
10:45 •
A rare case of a tracheoesophageal fistula
11:00 •
Recurrent sepsis and liver hamartoma’s ( Von Meyenburg’s Complexes).
11:15 •
Primary syphilitic proctitis
11:30 •
Transarterial embolization of hepatic arteriovenous malformations in a newborn
11:45 •
Auto-Brewery Syndrome in a patient after Roux-en-Y gastric bypass surgery: a case report
Room TEUN 3rd floor
09:00 •
Introduction
09:05 •
INVITED LECTURE : Intestinal polyposis syndromes
09:35 •
Heterotopic gastric mucosa in the gallbladder: a case report.
09:45 •
(Peri)anal basal cell carcinoma: a rare entity and diagnostic challenge on biopsy.
09:55 •
Pseudo-signet ring cells in endoscopic gastric biopsies : clinical and pathological features of 3 cases
10:45 •
INVITED LECTURE: Hereditary gastric cancer.
11:15 •
Epstein-Barr virus-associated gastric carcinoma undifferentiated non-small gastric cancer with PDL-1 expression. A case report.
11:25 •
An unusual polyp at the anorectal transition
11:35 •
Possible link between longstanding eosinophilic oesophagitis and the development of oesophageal cancer.
14:00 •
INVITED LECTURE: GIST and inherited gastrointestinal stromal tumour syndromes
14:30 •
Case presentations of hereditary GI cancer
16:00 •
CD70-positive colorectal cancer associated fibroblasts: prognostic marker and therapeutic target
16:10 •
T-cell infiltration assessed in pretherapeutic biopsies of patients with locally advanced rectal adenocarcinoma (LARC) is associated with tumor response and relapse after chemoradiotherapy (CRT) and rectal surgery.
16:20 •
Correlation of tumoral nuclei percentage with RAS mutant allele frequency in colorectal adenocarcinoma : a quality assessment tool of next generation sequencing analysis showing limited intra-tumoral heterogeneity for RAS mutation status
16:30 •
Right iliac fossa pain: role of imaging at the emergency department
16:40 •
Safety and efficacy of Transarterial Radioembolization following Chemoembolization with drug eluting beads for Hepatocellular Carcinoma
Room TIFFANY/SHAH 2nd floor
10:30 •
Introduction
10:35 •
Difficult-case discussion on portal hypertension
11:15 •
Young BASL Paper in the Picture
11:35 •
Young Belgian researcher abroad
11:55 •
Closing remarks
TIFFANY/SHAH 2nd floor
13:30 •
Breastfeeding and medications
14:00 •
Pharmacology of omeprazole
14:30 •
Immunosuppression in children
15:00 •
Syrup and alcohol
16:00 •
Impact of tube feeding on pulmonary function in children and adults with cystic fibrosis (CF): a registry study
16:10 •
Impact of tube feeding on nutritional status in children and adults with cystic fibrosis (CF): a registry study
16:20 •
STATE OF HYDRATION AFTER SPORTS IN OBESE CHILDREN BEFORE AND AFTER WEIGHT LOSS
16:30 •
BeSPGHAN General Assembly
Saturday
, February 11
Exhibition Area Room Belle
10:35 •
Coffee break
13:00 •
Lunch - sandwich buffet
Open Area 2nd floor
10:30 •
Coffee Break
12:45 •
Lunch
Room LIJN & TEUN 3rd floor
08:30 •
Introduction to the Brohée Prize
08:35 •
Brohée Prize: PNPLA3 gene in liver diseases
09:00 •
Successful dose de-escalation to adalimumab 40mg every three weeks in patients with Crohn’s disease
09:12 •
Placental growth factor inhibition prevents hepatopulmonary syndrome in mice
09:24 •
The impact of antithrombotics on immunochemical fecal occult blood testing for colorectal cancer screening
09:36 •
Prospective monocentric evaluation of the response to initial hepatitis B virus vaccination and revaccination in children with celiac disease
09:48 •
Early fibrostenosis in Crohn’s disease is associated with multiple susceptibility loci on Immunochip analysis
10:00 •
Apolipoprotein F affects hepatic phosphatidylcholine metabolism and is reduced in NASH in humans.
10:12 •
Discussion
10:15 •
Invited Lecture : Cell therapy in Crohn’s disease
11:00 •
Invited Lecture : Endoscopic treatment of early gastric cancer in Europe. Lessons from the East
11:20 •
Autologous hematopoietic stem cell transplantation into the liver in alcoholic hepatitis: what is the impact on liver histology and gene expression patterns?
11:32 •
Therapeutic manipulation of the gut microbiota through diet to reduce intestinal inflammation: results from the FIT trial
11:44 •
Anal problems during pregnancy and postpartum: a prospective cohort study.
11:56 •
Rapid, persistent Hepatitis B Viral DNA suppression predicts Nucleos(t)ide Analogue induced HBeAg seroconversion in a Belgian, predominantly Caucasian cohort of chronic hepatitis B patients
12:08 •
ypT0N+: the outcasts in pathological complete tumor response after neoadjuvant chemoradiation for esophageal cancer. How do they fare?
12:20 •
Long-term outcome and endoscopic healing rates following long modified side-to-side strictureplasties.
12:32 •
Discussion
12:35 •
BWGE Award Ceremony & Closing remarks
TIFFANY/SHAH 2nd floor
09:00 •
Welcome & Introduction
09:15 •
Images in IBD: What can we see?
09:45 •
Joint pain and IBD
10:15 •
Therapeutic treatment with Vedolizumab: A brief overview
11:00 •
Strategies to improve adherance in IBD
11:30 •
Short bowel syndrome
12:00 •
New treatments in IBD
12:30 •
IBD nurses as integral part of a multidisciplinary IBD team
12:40 •
End
Timezone
bwge2017
Europe/Brussels
Filter By Date
bwge2017
Feb 9
-
11, 2017
Thursday
, February 9
Friday
, February 10
Saturday
, February 11
Filter By Venue
Hilton, Antwerp, Belgium
Sort schedule by Venue
Belle Epoque 3rd floor
Exhibition Area Room Belle
Open Area 2nd floor
Room FLORENTINE 2nd floor
Room LIJN & TEUN 3rd floor
Room LIJN 3rd floor
Room Sancy 2nd floor
Room TEUN 3rd floor
Room TIFFANY/SHAH 2nd floor
TIFFANY/SHAH 2nd floor
Filter By Type
Basic short talks oral poster session
BASL Meeting
All
SESSION 1
SESSION 2
SESSION 3
SESSION 4
BeSPGHAN
All
Pharmacology in children - Session 1
Pharmacology in children - Session 2
BGDO
All
Highlights of the year
SESSION 1
Sesssion 2
BINA Nurses
All
SESSION 1
SESSION 2
BSGIE Symposium
All
SESSION 1
SESSION 2
Clinical short talks oral poster session
IBD/BIRD Session
All
SESSION 1
SESSION 2
SESSION 3
SESSION 4
Interactive Case Report Session
All
SESSION 1
SESSION 2
Plenary Session
All
SESSION 1
SESSION 2
Research Group: Belgian Pancreatic Club (BPC)
All
SESSION 1
SESSION 2
Research Group : GIREM 'Gastrointestinal regulatory mechanisms'
All
SESSION 1
SESSION 2
SESSION 3
SESSION 4
Satellite Symposia
Ultrasound Course
Working Group of Digestive Pathology
All
SESSION 1
SESSION 2
SESSION 3
SESSION 4
SESSION 5
Young BASL
Filter sessions
Apply filters to sessions.
close
Dates
Thursday
, February 9
Friday
, February 10
Saturday
, February 11
Venue
Belle Epoque 3rd floor
Exhibition Area Room Belle
Open Area 2nd floor
Room FLORENTINE 2nd floor
Room LIJN & TEUN 3rd floor
Room LIJN 3rd floor
Room Sancy 2nd floor
Room TEUN 3rd floor
Room TIFFANY/SHAH 2nd floor
TIFFANY/SHAH 2nd floor
Session Type
Basic short talks oral poster session
BASL Meeting
All
SESSION 1
SESSION 2
SESSION 3
SESSION 4
BeSPGHAN
All
Pharmacology in children - Session 1
Pharmacology in children - Session 2
BGDO
All
Highlights of the year
SESSION 1
Sesssion 2
BINA Nurses
All
SESSION 1
SESSION 2
BSGIE Symposium
All
SESSION 1
SESSION 2
Clinical short talks oral poster session
IBD/BIRD Session
All
SESSION 1
SESSION 2
SESSION 3
SESSION 4
Interactive Case Report Session
All
SESSION 1
SESSION 2
Plenary Session
All
SESSION 1
SESSION 2
Research Group: Belgian Pancreatic Club (BPC)
All
SESSION 1
SESSION 2
Research Group : GIREM 'Gastrointestinal regulatory mechanisms'
All
SESSION 1
SESSION 2
SESSION 3
SESSION 4
Satellite Symposia
Ultrasound Course
Working Group of Digestive Pathology
All
SESSION 1
SESSION 2
SESSION 3
SESSION 4
SESSION 5
Young BASL
Other Filters